AXON ENTERPRISE, INC.

CIK 1069183 · View on SEC EDGAR ↗

Portfolio value
$19.1M
#8,911 of 9,443 by 13F value · top 94.4%
Positions
1
As of
June 30, 2026

Portfolio value QoQ: +6.0% 13F does not disclose cash

Top 10 holdings weight
100.00%
Top 25 holdings weight
100.00%
Positions above 1%
1
Effective number of positions
1.0

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q2 2026: 0.0% Est. buys $0 · sells $0

Median holding: 7.0 quarters Tracked Q4 2024–Q2 2026 · 100.0% still held

New positions
0
Increased
0
Decreased
0
Closed
0
On this page

Performance vs S&P 500

Tracked Q4 2024–Q2 2026
-33.7%
S&P 500 total return (same window)
+28.1%
Excess return
-61.8%

Annualized: -24.0% · S&P 500: +18.0%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

Technology
100.0%

Full portfolio 1 positions

Type Streak 8Q trend
CLBT Cellebrite DI Ltd. - Ordinary Shares $19,126,190 100.00% 1,310,013 $1,074,211

Top movers (QoQ)

Security Action Shares Δ Value Δ
CLBT Price move only +0 +$1.1M